 |
|
|
|
|
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Nelson P. on PAPER: Sperling RA. et al., 2011, This is an interesting conversation among highly respected scientists. I'll just add one... 15 Dec 2011.
|
|
|
 |
|
|
Nelson P. on LIVE DISCUSSION: Reimagining Alzheimer's Disease—Time for Bright New Ideas?
, I have much respect for Dr. Herrup and for his scholarly review article. I agree that dementia... 26 Apr 2011.
|
|
|
|
|
|
Nelson P. on PAPER: Vilardo E. et al., 2010, The paper by Elisa Vilardo et al. on miR-101 regulating APP (Francesca Ruberti, corresponding... 22 Apr 2010.
|
|
|
|
|
|
Nelson P. on NEWS: MicroRNAs—Oligarchs of Oligodendrocyte Fate, These papers contain nice work. Since the work comes “in stereo” in a great journal, it seems... 12 Mar 2010.
|
|
|
|
|
|
Nelson P. on PAPER: Kim J. et al., 2007, Jongpil Kim and colleagues from Asa Abeliovich's group have produced a very important work that... 7 Sep 2007.
|
|
|
|
|
|
Nelson P. on PAPER: Centonze D. et al., 2007, The thrust of this paper is that the noncoding RNA BC1 is responsible for regulating D2-mediated... 28 Aug 2007.
|
|
|
|
|
|
Nelson P. on PAPER: Schaefer A. et al., 2007, Anne Schaefer et al. have produced an important study about miRNAs in the mouse cerebellum.... 24 Jul 2007.
|
|
|
|
|
|
Nelson P. on PAPER: Berg L. et al., 1998, A high-quality study from a well-respected group of clinicians and pathologists. 3 Jun 2002.
|
|
|
|
|
|
Nelson P. on PAPER: Busser J. et al., 1998, I think that the evidence of disruption/change of cell cycle protein expression in Alzheimers... 3 Jun 2002.
|
|
|
|
|
|
Nelson P. on PAPER: Askanas V. et al., 1998, An increasingly compelling model of AD pathology is IBM. 3 Jun 2002.
|
|
|
|
|
|
Nelson P. on PAPER: Pericak-Vance MA. et al., 1998 Jan-Feb, Insight into some possible new loci of AD genes. 3 Jun 2002.
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
